Detalles de la búsqueda
1.
A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
Oncologist
; 26(3): e367-e373, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33140457
2.
The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018).
BMC Complement Altern Med
; 14: 490, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25510341
3.
YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy.
Front Pharmacol
; 14: 1244655, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37860121
4.
Ganoderma tsugae Induces S Phase Arrest and Apoptosis in Doxorubicin-Resistant Lung Adenocarcinoma H23/0.3 Cells via Modulation of the PI3K/Akt Signaling Pathway.
Evid Based Complement Alternat Med
; 2012: 371286, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22792123
5.
YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity.
Front Pharmacol
; 13: 1095186, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36686648
6.
YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment.
Sci Rep
; 11(1): 13482, 2021 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34188068
7.
Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906).
Front Pharmacol
; 9: 1324, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30510512
8.
Safety surveillance of traditional Chinese medicine: current and future.
Drug Saf
; 38(2): 117-28, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25647717
9.
PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment.
Sci Rep
; 5: 9384, 2015 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25819872
10.
Increased anti-P-glycoprotein activity of baicalein by alkylation on the A ring.
J Med Chem
; 47(22): 5555-66, 2004 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-15481991
11.
First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer.
Cancer Chemother Pharmacol
; 73(2): 373-80, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24297682
12.
Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy.
J Ethnopharmacol
; 140(3): 614-23, 2012 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22326673
13.
A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer.
Clin Colorectal Cancer
; 10(2): 85-96, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21859559
14.
The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.
Sci Transl Med
; 2(45): 45ra59, 2010 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-20720216
15.
A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906.
Chin Med
; 5: 30, 2010 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20727161
16.
Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinoma.
Anticancer Res
; 29(10): 4083-92, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19846955
17.
Liquid chromatography/mass spectrometry analysis of PHY906, a Chinese medicine formulation for cancer therapy.
Rapid Commun Mass Spectrom
; 21(22): 3593-607, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17944003
Resultados
1 -
17
de 17
1
Próxima >
>>